INTAKE OF OMEGA-3 POLYUNSATURATED FATTY ACIDS AND ASSOCIATIONS WITH CARDIOMETABOLIC RISK FACTORS - A DISSERTATION
UNIVERSITY OF MINNESOTA, NOELLE NICOLE GRONROOS, Sept 2017
- Review of role of Vitamin D in Cardiometabolic diseases – Jan 2013
- Vitamin D Deficiency, Obesity and Cardiometabolic Risk: Is there any Relationship - Jan 2010
- Heart problems in obese increase if deficient in BOTH Vitamin D and Magnesium – Aug 2017
- Overview Metabolic Syndrome and vitamin D
- Omega-3 in infancy reduces Obesity following antibiotic (confirmed in rats, suspected in humans) – Feb 2016
- Hypothesis – Omega-6 to Omega-3 ratio increases obesity – Nov 2015
- All items in category Metabolic Syndrome
105 items Omega-3 and Cardiovascular (items in both categories in VitaminDWiki)
- Omega-3 reduces many aspects of heart problems - Jan 2024
- Cardiovascular problems reduced by Omega-3 - many studies
- Cardiovascular problems are prevented by Vitamin D plus Omega-3 – Feb 2023
- Omega-3 decreases heart disease and COVID: Harris and Patrick, video and transcript - Dec 2021
- Atrial Fibrillation decreased by Vitamin D or Magnesium - many studies
- Omega-3 reduced cardiovascular deaths by 16 percent (427,678 people) – March 2020
- Synthetic EPA drug recommended to FDA for Cardio (Omega-3 is 8 X better) – Nov 2019
- Omega-3 reduces heart problems by ~5 percent – meta-analysis by Heart Association Oct 2019
- Cardiovascular Prevention with Omega-3 (finally using high doses) – Sept 2019
- Few people have enough EPA (an Omega-3) to reduce heart failures – July 2019
- Another Nail in the Coffin for Fish Oil Supplements (nope) – JAMA April 2018
- Omega-3 provides many cardiovascular benefits – April 2018
- Omega-3 helps the heart, AHA class II recommendation, more than 1 gm may be needed – March 2018
- 3 days of Omega-3 before cardiac surgery reduced risk of post-op bleeding by half – RCT March 2018
- Perhaps the Omega-3 optimal level is 10 percent, not 8 – Feb 2018
- Omega-3 Cardiovascular meta-analysis has at least 5 major problems – Jan 2018
- Benefits of Omega-3 beyond heart health - LEF Feb 2018
- Higher Omega-3 index (4 to 8 percent) associated with 30 percent less risk of coronary disease (10 studies) July 2017
- Cardiovascular problems reduced by low dose aspirin and perhaps Omega-3 (also Vit K) – Sept 2017
- Omega-3 reduced time in hospital and atrial fibrillation after cardiac surgery – meta-analysis May 2016
- For every Omega-3 dollar there is a 84 dollar savings in Cardiovascular costs - Foster and Sullivan April 2016
- High dose Omega-3 probably reduces heart problems – American Heart Association – March 2017
- Health problems prevented by eating nuts (perhaps due to Magnesium and or Omega-3) – meta-analysis Dec 2016
- Omega-3 – need more than 1 gram for a short time to reduce Cardiovascular Disease – Nov 2016
- Omega-3 is vital for health, mail-in test is low cost and accurate
- Cardiovascular calcification prevented by Omega-3, Magnesium, Vitamin K, and Vitamin D – April 2015
- Atrial fibrillation sometimes treated by Omega-3 – meta-analysis Sept 2015
- Salmon intervention (vitamin D and Omega-3) improved heart rate variability and reduced anxiety – Nov 2014
- Omega-7 - in addition to Omega-3
- Omega-3 reduces Coronary Heart Disease - infographic June 2014
- Cardiovascular diseases – conflicting data on benefits of Omega-3 and vitamin D – Feb 2014
- Cardiovascular system benefits from both Omega-3 and vitamin D – Dec 2012
- Heart problems such as Afib related to little Magnesium, Omega-3, Vitamin D getting to tissues
- Omega-3 does not help heart patients – meta-analysis Sept 2012
Omega-3 and Obesity (items in both categories)
- Omega-3 added to father’s diet reduced offspring’s obesity (mice) – June 2024
- Overweight needed more EPA (4 grams) to fight depression – RCT Aug 2022
- 4 weeks of Omega-3 better than 2 week 800 calorie diet before Bariatric Surgery – RCT March 2019
- Omega-3 may reduce weight gain and maintain weight loss – Aug 2018
- Severe Non-Alcoholic fatty liver disease treated by Omega-3 – RCT April 2018
- How Omega-3 fights metabolic syndrome and weight – Feb 2018
- NAFLD in children nicely treated by combination of Vitamin D and Omega-3 – RCT Dec 2016
- Obese youths 2X less likely to develop Metabolic Syndrome if take Omega-3 – RCT April 2016
- Omega-3 in infancy reduces Obesity following antibiotic (confirmed in rats, suspected in humans) – Feb 2016
- Huge increases in Omega-6 to Omega-3 ratio increase risk of obesity, etc. – March 2016
- Overweight women on caloric restriction diet got 3X benefits from 8 weeks of Omega-3 – RCT Dec 2015
- Hypothesis – Omega-6 to Omega-3 ratio increases obesity – Nov 2015
- Omega-3 reduced vitamin D3 inflammation for obese – RCT Jan 2013
- Reasons for low response to vitamin D
See also PubMed
- Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future Aug 2017, PDF is behind $89 paywall
- A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk Mayo Jan 2017,  Download the 3 page PDF from VitaminDWiki
 Download the PDF from VitaminDWiki
Abstract
Background: The American Heart Association (AHA) and the American Diabetes Association (ADA) recommend at least two servings of oily fish a week to promote cardiovascular health. Oily fish is rich in the long-chain omega-3 polyunsaturated fatty acids (PUFAs) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). These, along with the vegetable-derived omega-3 PUFA alpha-linolenic acid (ALA), play major roles in normal physiological processes. The aim of this dissertation was to consider associations of fish, fish-derived omega-3 PUFAs DHA and EPA, and vegetable-derived omega-3 PUFA ALA with cardiovascular and glycemia outcomes, presented in three related manuscripts.Methods: All analyses utilized data from the Atherosclerosis Risk in Communities (ARIC) Study, a multi-center prospective study designed to investigate the etiology and natural history of cardiovascular disease. There have been five visits: the baseline in 1987-89 (visit 1) and four follow-up visits in 1990-92, 1993-95, 1996-98 and 2011-13. Data from visits 1 through 4 were used in this dissertation. Dietary data were collected at visits 1 and 3 via food frequency questionnaire (FFQ). Paper 1: We studied the association of consumption of seafood, EPA, DHA, and ALA with fasting blood glucose (FBG) (n=13,173), HbA1c (n=11,575), and incident type 2 diabetes (T2D) (n=11,874).
FBG and HbA1c were obtained using blood samples collected during study visits and diabetes status was identified through self-report and lab values. To estimate differences across exposure categories, linear regression was used for continuous outcomes (FBG, HbAlc), adjusting for repeated measures as appropriate; Cox proportional hazards regression with time varying covariates was used for the incident T2D outcome. Paper 2: We studied the association of consumption of seafood, EPA, DHA, and ALA with J-point height and heart rate-corrected (QTc) interval (n = 12,611). QTc interval and J-point height were measured using ECGs obtained during study visits. To estimate differences across exposure categories, generalized estimating equations were used to estimate odds ratios of prolonged QTc and J-point elevation and differences in continuous measures of QTc interval and J-point height. Paper 3: One ARIC field center collected plasma biomarker values from participants at visit 1, and these data were used to augment self-report dietary data obtained via FFQ. We imputed biomarker values for other participants using multiple imputation for chained equations and investigated the associations of plasma phospholipid measures of ALA, DHA, and EPA with prolonged QTc, HbA1c, and incident T2D.
Results: Paper 1: In multivariable analyses, intake of seafood and DHA+EPA was favorably associated with FBG and HbA1c in non-diabetic participants, although the magnitude of the associations was small. ALA was not associated with FBG or HbA1c in non-diabetic participants. Among diabetic participants, intake of seafood, DHA+EPA, and ALA were adversely associated with FBG and HbA1c, with differential effects for seafood by sex and race. Finally, higher intake of ALA was associated with higher risk of incident T2D in normoglycemics, while seafood and DHA+EPA were not. Paper 2: Higher intakes of ALA+DHA+EPA and ALA were associated with a shorter QTc interval.
None of the exposures were associated with prolonged QTc, J-point elevation, or J-point height. Paper 3: In the full cohort (imputed) and the Minnesota (observed) populations, none of the exposures was significantly associated with prolonged QTc, HbA1c, or incident T2D. Point estimates in both populations were similar across different covariate adjustments, and confidence intervals were narrower in the full cohort population than in the observed plasma population.Conclusions: Considering the dietary recommendations of the ADA and AHA, this dissertation examined the associations of dietary omega-3 PUFAs with cardiovascular and glycemia outcomes while also considering the implications of measurement error in the exposure of interest. Taken together, these results suggest that consumption of omega-3 PUFAs are not associated with certain cardiovascular outcomes in healthy individuals, and may be associated with deleterious glucose homeostasis in those with diabetes.
Titles of manuscripts in the dissertation
- THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - DATA AND DATA COLLECTION
- INTAKE OF LONG-CHAIN OMEGA-3 POLYUNSATURATED FATTY ACIDS, INCIDENCE OF DIABETES, AND MARKERS OF GLUCOSE HOMEOSTASIS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
- INTAKE OF OMEGA-3 POLYUNSATURATED FATTY ACIDS AND ELECTROCARDIOGRAPHIC PREDICTORS OF SUDDEN CARDIAC DEATH IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC)
5571 visitors, last modified 05 Dec, 2017,